NEW YORK, Jan. 7 /PRNewswire/ -- The American Stock Exchange LLC(R) (Amex(R)) announced today its final determination to remove the common stock (the "Securities") of Samaritan Pharmaceuticals, Inc. from listing on the Exchange, and filed an application on Form 25 to strike the Securities from listing with the Securities and Exchange Commission (the "SEC"). The delisting will become effective on January 17, 2008 unless postponed by the SEC.
Pursuant to its rules, the Exchange provided notice to Samaritan Pharmaceuticals, Inc. of the decision to delist the Securities and an opportunity to appeal the decision to a panel designated by the Exchange's Board of Governors.
In addition to this press release, the Exchange will provide public notice of its determination on its website. Notice will remain posted on the website until the delisting is effective.
About The American Stock Exchange
The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 381 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit http://www.amex.com.
|SOURCE American Stock Exchange|
Copyright©2008 PR Newswire.
All rights reserved